July 9, 2013

The Food and Drug Administration has approved a new drug for treating opioid dependence.

July 9, 2013

The U.S. healthcare system has saved $25.5 billion over seven years from generic drugs launched under patent settlements between branded and generic drug manufacturers, according to a new study.

July 9, 2013

With some studies showing that patients' failure to take their medications as directed costs the economy nearly $300 billion per year, one group is looking to tackle what it sees as part of the problem: doctors' and pharmacists' instructions to patients on how much medicine to take and when.

July 9, 2013

The U.S. Public Health Service has awarded a Touro College of Pharmacy student for his efforts to educate the public about health care.

July 8, 2013

Drug maker AbbVie has hired the co-host of TLC's "What Not to Wear" to promote a new psoriasis marketing campaign, the company said Monday.

July 8, 2013

AmerisourceBergen announced that its national network of Good Neighbor Pharmacy owners and more than 250 exhibitors from across the pharmaceutical supply chain will be on hand July 24 to 27 in Las Vegas for ThoughtSpot 2013.

July 8, 2013

Inquiries by pharmacists with doctors regarding the rationale behind prescriptions, diagnoses and treatment plans are inappropriate, according to a new resolution by the American Medical Association.

July 8, 2013

Medical products manufacturer Becton, Dickinson and Co. has appointed Christopher Reidy as its CFO, the company, more commonly known as BD, said Monday.

July 8, 2013

Nearly 30 children have been accidentally poisoned by opioid painkiller patches since 1997, according to the Food and Drug Administration, prompting the agency to issue disposal guidelines.

July 8, 2013

A chronic obstructive pulmonary disease and asthma drug made by Sunovion infringes Mylan's patents on a similar drug, a federal judge has ruled, Mylan said.

July 8, 2013

Fewer Americans are undergoing lower-limb amputations, a statistic that indicates advances in treating foot ulcers related to diabetes, according to a new study.

July 8, 2013

Impax Labs has appointed Mary Pendergast to its board of directors, the generic drug maker said.

July 8, 2013

More than half of the estimated 5.4 million Americans with Alzheimer's disease and other forms of dementia are at risk of wandering and becoming lost, according to the National Institute on Aging, a figure that has prompted the federal government to develop a series of training videos for police.

July 8, 2013

Reporting their results July 8 in Cancer Cell, researchers say their successful laboratory tests in human MDS cells and mouse models of MDS provide a molecular target for designing new drugs to battle a syndrome with few effective treatments.

July 3, 2013

Drug maker Impax Labs is hoping to become the first to market a generic version of a drug used to treat incontinence and overactive bladder, the company said Wednesday.

July 3, 2013

Oregon Gov. John Kitzhaber, a Democrat, has signed what the National Association of Community Pharmacy has characterized as groundbreaking reform legislation that applies reasonable standards to how pharmacy benefit managers audit community pharmacies, provides increased transparency into generic prescription drug reimbursement and ensures that PBM administrators of prescription drug claims are registered within the state.

July 2, 2013

Arthritis is one of the most common chronic illnesses in children, but it often goes unnoticed and undiagnosed, according to two arthritis-focused organizations seeking to spread awareness about the disease.

July 2, 2013

A dramatic increase in the number of women dying from opioid painkiller overdoses has health officials alarmed.

July 2, 2013

BioPlus Specialty Pharmacy has been added to the limited-distribution network for a Genentech drug used to treat lung and pancreatic cancers.

July 2, 2013

Covidien has finished spinning off its pharmaceuticals division, the medical products maker said.

July 2, 2013

A cancer drug made by Genentech and Astellas is no longer available through ordinary retail channels and is now available only through a limited-distribution network.

July 2, 2013

The Food and Drug Administration has approved a gel formulation of a foot fungus drug made by Merz Pharmaceuticals, according to published reports.

July 2, 2013

Sandoz, the generics division of Swiss drug maker Novartis, announced the launch of metronidazole 1% topical gel, calling it the first generic version of Galderma Labs' Metrogel.

July 2, 2013

Sandoz has started a late-stage clinical trial of a biosimilar version of a drug used to treat autoimmune disorders, hoping the results will support its efforts to win regulatory approval in the United States and Europe.